跳至主要内容
临床试验/NCT01494870
NCT01494870Unknown不适用

Management of Acute Myocardial Infarction in the Presence of Left Bundle Branch Block

Samara Regional Cardiology Dispensary2 个研究点 分布在 2 个国家目标入组 300 人开始时间: 2012年1月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
300
试验地点
2
主要终点
mortality

研究概览

简要总结

The primary objective of this study is to propose new treatment algorithm (strategy) for patients with Acute Coronary Syndrome (ACS) and left bundle-branch block (LBBB).

详细描述

Current recommendations on the treatment of acute coronary syndrome (ACS) dictate urgent reperfusion therapy in the case of evolving myocardial infarction with ST-segment elevation (STEMI). Optimal use of PCI (preferably) or thrombolysis in this situation requires a rapid and correct diagnosis.

According to the ESC'2008 and ACC/AHA'2009 focused update guidelines patients admitted to the hospital within 12 hours after the onset of chest pain with new (or presumably new) left bundle-branch block (LBBB) should be treated like patients having STEMI (class I, level A). However, it is well-known that in patients with concomitant LBBB, the ECG manifestations of acute myocardial injury may be masked.

ACS may occur in a patient with "true old" LBBB (when doctor has/has not an ability to compare the new ECG with the previous one) or (presumably) new LBBB.

There is a high risk of non receiving appropriate therapy or of receiving inappropriate therapy (thrombolysis instead of LMWH/UFH/fondaparinux).

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18 - 75 years
  • Ischemic discomfort (ie, ischemic chest pain or equivalent) at rest ≥20 minutes within previous 24 hours.
  • Any (new, presumably new, or old) LBBB on the prehospital (ambulance) or admission ECG.
  • Urgent coronary angiography (followed, when indicated, by PCI), ideally within 90 minutes after admission

排除标准

  • all-comers design

结局指标

主要结局

mortality

时间窗: 30 days

次要结局

  • Number of participants survived(1 year)

研究者

发起方
Samara Regional Cardiology Dispensary
申办方类型
Other
责任方
Principal Investigator
主要研究者

Ass.Prof. Dmitry Duplyakov M.D., Ph.D.

Medical Director, Cardiology Department

Samara Regional Cardiology Dispensary

研究点 (2)

Loading locations...

相似试验